“EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 16, no. 1, Aug. 2024, p. e2024073, https://doi.org/10.4084/MJHID.2024.073.